Status:
UNKNOWN
Continuous Glucose Monitoring in Peri-operative Period in Kidney Transplant Recipients
Lead Sponsor:
Seoul National University Hospital
Conditions:
New Onset Diabetes After Transplantation
Eligibility:
All Genders
18+ years
Brief Summary
his study aims to utilize Continuous Glucose Monitoring (CGM) to observe glucose fluctuations in kidney transplant recipients and predict New-Onset Diabetes After Transplantation (NODAT) based on thes...
Eligibility Criteria
Inclusion
- The study will target 100 kidney transplant patients who have provided consent, among those who underwent the procedure at Seoul National University Hospital after March 2021.
Exclusion
- multi-organ transplant
- history of previous kidney transplant
- less than 18 years old
Key Trial Info
Start Date :
May 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06012799
Start Date
May 15 2021
End Date
December 30 2024
Last Update
April 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea, 110-744